Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02163408 · ClinicalTrials.gov registry record
3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery
A clinical trial, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 134
- Enrollment target
NCT02163408 is a clinical trial that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 134 participants.
The verdict
NCT02163408 has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 134 participants
- Enrollment target
Study Summary
This is a technical development study with the goal to develop 3D techniques for atherosclerosis plaque characterization. We hypothesize that 3D MRI is superior to 2D MRI in characterizing major plaque constituents that contribute to severe clinical events such as myocardial infarction or stroke. The major advantages of the 3D techniques to be developed will include high spatial resolution, reduced scan times, and optimized image contrast. The use of contrast injection is not needed with the new techniques, which is greatly beneficial for patients with advanced chronic kidney disease.This is not a funded clinical trial.
Interventions
- OTHER MRI with/without contrast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2014-06-24 |
| Est. Completion | 2022-04-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02163408
The ClinicalTrials.gov registry entry for NCT02163408 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI with/without contrast is the first listed.
NCT02163408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02163408 about?
NCT02163408 is a clinical study titled "3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery". This is a technical development study with the goal to develop 3D techniques for atherosclerosis plaque characterization. We hypothesize that 3D MRI is superior to 2D MRI in characterizing major plaque constituents that contribute to severe clinical events such as myocardial infarction or stroke. Th...
What is the current status of trial NCT02163408?
This trial is currently completed. The enrollment target is 134 participants. The study started on 2014-06-24. Estimated completion is 2022-04-25.
What interventions are being tested in trial NCT02163408?
The interventions under investigation include: MRI with/without contrast (OTHER).
Who is sponsoring clinical trial NCT02163408?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.